Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition

// Takaaki Oba 1 and Ken-Ichi Ito 1 1 Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery II, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Japan Correspondence to: Ken-Ichi Ito, email: kenito@shinshu-u.ac.jp Keywords: eribulin; paclitaxel; triple-negative breast cancer; epithelial-mesenchymal transition; mesenchymal-epithelial transition Received: December 26, 2017     ...